Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Foghorn Therapeutics (FHTX) Accumulated Depreciation & Amortization (2020 - 2025)

Foghorn Therapeutics (FHTX) has 6 years of Accumulated Depreciation & Amortization data on record, last reported at $3.3 million in Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 5.77% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, up 5.77%, while the annual FY2025 figure was $3.3 million, 5.77% up from the prior year.
  • Accumulated Depreciation & Amortization reached $3.3 million in Q4 2025 per FHTX's latest filing, up from $2.5 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $3.5 million in Q4 2023 and bottomed at $800000.0 in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $1.9 million, with a median of $1.7 million recorded in 2022.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 300.0% in 2021, then plummeted 43.75% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $3.2 million in 2021, then rose by 3.12% to $3.3 million in 2022, then grew by 6.06% to $3.5 million in 2023, then dropped by 10.86% to $3.1 million in 2024, then increased by 5.77% to $3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $3.3 million in Q4 2025, $2.5 million in Q3 2025, and $900000.0 in Q2 2025.